Stockhead’s resident Health and Biotech expert Tim Boreham is putting down the microscope and picking up the microphone for another instalment of The Health Kick Podcast.

In this episode Tim chats with Brad O’Connor, managing director and CEO of Cogstate (ASX:CGS).

Cogstate is a neuroscience technology company focused on improving brain health assessments to advance the development of new medicines and to enable earlier clinical insights in healthcare.

The company began an impressive recovery in March, rising some 30 per cent off the back of impressive 2020 sales figures.

So tune in to hear to pair discuss the Cogstate’s origins, its clinical and pharma upside and what’s on the horizon for the medtech company.

On mobile? Click here to listen with Apple podcasts, here for Spotify or here for Google Podcasts.

Like to listen to podcasts through another app? Just search for The Health Kick Podcast with Tim Boreham and subscribe!